<p><em>新的研究发现，三分之二的员工从未被告知有关储蓄计划的信息，即使员工在药房柜台做出经济牺牲</em></p>
<p>, /PRNewswire/ -- 根据医疗科技公司 Buzz Health 的新研究，94% 的 HR、CFO 和福利领导表示，他们非常或极有可能采用一种工具，以帮助教育员工了解处方药的可负担性，因此美国雇主对处方药储蓄解决方案的需求几乎是普遍的。</p>
<p>研究结果的紧迫性进一步加大，伴随一项消费者调查：三分之二的美国工人（67%）表示，他们的雇主从未告知他们可以降低处方药费用的工具或计划。在因处方药费用而做出牺牲的员工中，55% 报告称他们的雇主从未告知他们可以提供帮助的计划。</p>
<p>研究结果还显示，这种缺乏意识带来了实际后果：43% 的全职员工报告称，在过去一年中因为处方药费用过高而做出了至少一次健康或经济上的牺牲，包括延迟处方药的领取、跳过药物和减少食品支出。值得注意的是，支付 35 美元或更多自付费用的员工在药房柜台放弃处方的可能性显著更高，这一门槛对雇主来说意味着显著的配药率风险。</p>
<p>这些发现来自 Buzz Health 对 1,007 名全职员工和 250 名医疗福利决策者的调查。超过四分之一的决策者（27%）承认他们公司的健康计划未能充分保护员工免受高处方药费用的影响，47% 表示他们的组织没有采取任何措施来解决处方药的可负担性。后果超出了药房柜台。在因处方药费用而做出牺牲的员工中，55% 报告称他们的雇主从未告知他们可以提供帮助的计划，42% 的决策者将处方药的可负担性视为员工流失的一个因素。</p>
<p>&#34;想象一下，一个员工在药房柜台面临选择：是需要的药物还是他们的食品，而一个可以提供帮助的储蓄计划却在他们的福利门户中未被发现，&#34;Buzz Health 的总裁 Joseph Kleiman 说。&#34;这一时刻每年发生数百万次，而这一切完全是可以预防的。雇主已经掌握了答案。整个处方药旅程中最强大的干预措施可能仅仅是告诉人们已经存在的计划。&#34;</p>
<p>合规文档被证明是促使雇主从兴趣转向行动的决定性因素。面对涵盖 HIPAA、ERISA、无惊讶法案和 SOC 2 认证的正式合规简报的雇主，有 90% 的可能性会采用解决方案，而未接触这些简报的雇主则为 63%。虽然雇主和经纪人都将合规视为关键的信任杠杆，但经纪人整体上表现出更多的犹豫，这表明在顾问驱动的销售渠道中，投资回报文档与合规材料可能同样重要。</p>
<p>Buzz Health 通过 RxCompare®解决了这一差距，这是一个获得 HITRUST 认证的定价透明平台，可以嵌入员工已经使用的会员门户中。RxCompare 允许员工实时比较来自多个折扣卡提供商的价格与他们在首选药房的保险共付额，并在药物未被覆盖时自动显示最佳可用现金价格。雇主可以以零实施成本参与。</p>
<p><strong>方法论</strong> 研究结果来自两项独立的 Buzz Health 调查：对 1,007 名全职美国员工和 250 名医疗福利决策者关于处方药可负担性和雇主福利沟通的研究，以及对 32 名雇主和 11 名福利经纪人的针对性脉搏调查，考察处方药储蓄解决方案的采用可能性和决策驱动因素。</p>
<p><strong>关于 Buzz Health</strong> Buzz Health 是一家医疗科技公司，通过其集成平台（包括 BuzzRx、RxCompare 和其专有的 Buzz Health 裁定技术）提供智能、可定制的处方解决方案。Buzz Health 的技术旨在规模和灵活性，帮助简化药房操作、实时优化索赔，并改善整个处方生态系统的可及性和可负担性。通过作为处方药储蓄和福利导航背后的智能层，Buzz Health 实现可衡量的成本降低、改善的依从性和更好的健康结果。</p>
<p><strong>媒体联系</strong>[email protected]</p>
<p>来源 Buzz Health</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNzA4Jk5ld3NJdGVtSWQ9Tlk5OTg4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA3MDgwODA3UFJfTkVXU19VU1BSX19fX19OWTk5ODg3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNzA4Jk5ld3NJdGVtSWQ9Tlk5OTg4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA3MDgwODA3UFJfTkVXU19VU1BSX19fX19OWTk5ODg3"/></p>

<p>一项 Buzz Health 的调查显示，94% 的美国雇主可能会采用处方药节省工具，但 67% 的员工对此类项目仍然不知情。这一沟通差距导致许多员工因药品费用高昂而做出财务或健康上的牺牲。研究强调，提供合规文档显著提高了雇主的采用率，强调了改善福利沟通以提高可负担性和员工留存率的必要性</p>

<p><em>New research finds that two in three employees are never informed about savings programs, even as workers make financial sacrifices at the pharmacy counter</em></p>
<div class="lb-trans"><p><em>新的研究发现，三分之二的员工从未被告知有关储蓄计划的信息，即使员工在药房柜台做出经济牺牲</em></p>
</div><p>, /PRNewswire/ -- Demand for prescription savings solutions is near-universal among U.S. employers, with 94% of HR, CFO, and benefits leaders saying they were very or extremely likely to adopt a tool that would help educate employees on prescription affordability, according to new research from Buzz Health, a healthcare technology company driving connection across the prescription ecosystem.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 根据医疗科技公司 Buzz Health 的新研究，94% 的 HR、CFO 和福利领导表示，他们非常或极有可能采用一种工具，以帮助教育员工了解处方药的可负担性，因此美国雇主对处方药储蓄解决方案的需求几乎是普遍的。</p>
</div><p>The findings take on added urgency alongside a companion consumer survey: two in three American workers (67%) say their employer has never told them about tools or programs that could lower their prescription drug costs. Among employees who made sacrifices due to prescription costs, 55% reported their employer had never informed them about programs that could have helped.</p>
<div class="lb-trans"><p>研究结果的紧迫性进一步加大，伴随一项消费者调查：三分之二的美国工人（67%）表示，他们的雇主从未告知他们可以降低处方药费用的工具或计划。在因处方药费用而做出牺牲的员工中，55% 报告称他们的雇主从未告知他们可以提供帮助的计划。</p>
</div><p>Findings also show that this lack of awareness carries real consequences: 43% of full-time employees reported making at least one health or financial sacrifice in the past year because a prescription was too expensive, including delaying prescription fulfillment, skipping medications, and cutting back on groceries. Notably, employees who paid $35 or more out of pocket for a prescription were significantly more likely to abandon it at the pharmacy counter, a threshold that signals meaningful fill-rate risk for employers.</p>
<div class="lb-trans"><p>研究结果还显示，这种缺乏意识带来了实际后果：43% 的全职员工报告称，在过去一年中因为处方药费用过高而做出了至少一次健康或经济上的牺牲，包括延迟处方药的领取、跳过药物和减少食品支出。值得注意的是，支付 35 美元或更多自付费用的员工在药房柜台放弃处方的可能性显著更高，这一门槛对雇主来说意味着显著的配药率风险。</p>
</div><p>The findings come from a Buzz Health survey of 1,007 full-time employees and 250 healthcare benefit decision-makers. More than one in four decision-makers (27%) admitted that their company's health plan fails to adequately protect employees from high prescription costs, and 47% said their organization has taken no steps to address prescription affordability. The consequences reach beyond the pharmacy counter. Among employees who made sacrifices due to prescription costs, 55% reported their employer had never informed them about programs that could have helped, and 42% of decision-makers cited prescription affordability as a factor in employee turnover.</p>
<div class="lb-trans"><p>这些发现来自 Buzz Health 对 1,007 名全职员工和 250 名医疗福利决策者的调查。超过四分之一的决策者（27%）承认他们公司的健康计划未能充分保护员工免受高处方药费用的影响，47% 表示他们的组织没有采取任何措施来解决处方药的可负担性。后果超出了药房柜台。在因处方药费用而做出牺牲的员工中，55% 报告称他们的雇主从未告知他们可以提供帮助的计划，42% 的决策者将处方药的可负担性视为员工流失的一个因素。</p>
</div><p>&#34;Picture an employee at the pharmacy counter choosing between a needed medication and their groceries, while a savings program that could have helped sits undiscovered in their benefits portal,&#34; said Joseph Kleiman, President of Buzz Health. &#34;That moment plays out millions of times a year, and it is entirely preventable. Employers already hold the answer. The most powerful intervention in the entire prescription journey may simply be telling people about the program that already exists.&#34;</p>
<div class="lb-trans"><p>&#34;想象一下，一个员工在药房柜台面临选择：是需要的药物还是他们的食品，而一个可以提供帮助的储蓄计划却在他们的福利门户中未被发现，&#34;Buzz Health 的总裁 Joseph Kleiman 说。&#34;这一时刻每年发生数百万次，而这一切完全是可以预防的。雇主已经掌握了答案。整个处方药旅程中最强大的干预措施可能仅仅是告诉人们已经存在的计划。&#34;</p>
</div><p>Compliance documentation proved to be the deciding factor in moving employers from interest to action. Employers presented with a formal compliance brief covering HIPAA, ERISA, the No Surprises Act, and SOC 2 certification were 90% likely to adopt a solution — compared to 63% among those who were not. While employers and brokers both cite compliance as a key trust lever, brokers showed more hesitation overall, suggesting that ROI documentation alongside compliance materials may be important for advisor-driven sales channels.</p>
<div class="lb-trans"><p>合规文档被证明是促使雇主从兴趣转向行动的决定性因素。面对涵盖 HIPAA、ERISA、无惊讶法案和 SOC 2 认证的正式合规简报的雇主，有 90% 的可能性会采用解决方案，而未接触这些简报的雇主则为 63%。虽然雇主和经纪人都将合规视为关键的信任杠杆，但经纪人整体上表现出更多的犹豫，这表明在顾问驱动的销售渠道中，投资回报文档与合规材料可能同样重要。</p>
</div><p>Buzz Health addresses this gap with RxCompare®, a HITRUST-certified pricing transparency platform, which can be embedded in the member portals employees already use. RxCompare lets employees compare real-time prices from multiple discount card providers against their insurance copay at their preferred pharmacy — and automatically surfaces the best available cash price when a medication isn't covered. Employers can participate with zero implementation cost.</p>
<div class="lb-trans"><p>Buzz Health 通过 RxCompare®解决了这一差距，这是一个获得 HITRUST 认证的定价透明平台，可以嵌入员工已经使用的会员门户中。RxCompare 允许员工实时比较来自多个折扣卡提供商的价格与他们在首选药房的保险共付额，并在药物未被覆盖时自动显示最佳可用现金价格。雇主可以以零实施成本参与。</p>
</div><p><strong>Methodology</strong> Findings draw from two separate Buzz Health surveys: a study of 1,007 full-time American employees and 250 healthcare benefit decision-makers on prescription affordability and employer benefits communication, and a targeted pulse survey of 32 employers and 11 benefits brokers examining adoption likelihood and decision drivers for prescription savings solutions.</p>
<div class="lb-trans"><p><strong>方法论</strong> 研究结果来自两项独立的 Buzz Health 调查：对 1,007 名全职美国员工和 250 名医疗福利决策者关于处方药可负担性和雇主福利沟通的研究，以及对 32 名雇主和 11 名福利经纪人的针对性脉搏调查，考察处方药储蓄解决方案的采用可能性和决策驱动因素。</p>
</div><p><strong>About Buzz Health</strong> Buzz Health is a healthcare technology company delivering intelligent, customizable prescription solutions through its integrated platforms, including BuzzRx, RxCompare, and its proprietary Buzz Health Adjudication Technology. Designed for scale and flexibility, Buzz Health's technology helps streamline pharmacy operations, optimize claims in real time, and improve access and affordability across the prescription ecosystem. By serving as the intelligence layer behind prescription savings and benefit navigation, Buzz Health enables measurable cost reductions, improved adherence, and better health outcomes.</p>
<div class="lb-trans"><p><strong>关于 Buzz Health</strong> Buzz Health 是一家医疗科技公司，通过其集成平台（包括 BuzzRx、RxCompare 和其专有的 Buzz Health 裁定技术）提供智能、可定制的处方解决方案。Buzz Health 的技术旨在规模和灵活性，帮助简化药房操作、实时优化索赔，并改善整个处方生态系统的可及性和可负担性。通过作为处方药储蓄和福利导航背后的智能层，Buzz Health 实现可衡量的成本降低、改善的依从性和更好的健康结果。</p>
</div><p><strong>Media Contact</strong>[email protected]</p>
<div class="lb-trans"><p><strong>媒体联系</strong>[email protected]</p>
</div><p>SOURCE Buzz Health</p>
<div class="lb-trans"><p>来源 Buzz Health</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNzA4Jk5ld3NJdGVtSWQ9Tlk5OTg4NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA3MDgwODA3UFJfTkVXU19VU1BSX19fX19OWTk5ODg3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY99887&amp;Transmission_Id=202607080807PR_NEWS_USPR_____NY99887&amp;DateId=20260708"/></p>

在药品成本不断上升的情况下，94% 的雇主准备增加处方节省工具